Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J.

J Hepatol. 2001 May;34(5):730-9.

PMID:
11434620
2.

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.

Costa LB, Ferraz ML, Perez RM, Ferreira AS, Matos CA, Lanzoni VP, Silva AE.

Braz J Infect Dis. 2002 Oct;6(5):219-24.

PMID:
12495603
3.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
4.

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B.

J Hepatol. 1998 Jul;29(1):12-9.

PMID:
9696487
5.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

6.

Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?

Guido M, Bortolotti F, Leandro G, Jara P, Hierro L, Larrauri J, Barbera C, Giacchino R, Zancan L, Balli F, Crivellaro C, Cristina E, Pucci A, Rugge M.

Am J Gastroenterol. 2003 Mar;98(3):660-3.

PMID:
12650803
7.

Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.

Vădan R, Gheorghe L, Becheanu G, Iacob R, Iacob S, Gheorghe C.

Rom J Gastroenterol. 2003 Sep;12(3):183-7.

PMID:
14502317
8.

Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C--a study of 527 patients at one establishment.

Matsumura H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y.

J Viral Hepat. 2000 Jul;7(4):268-75.

PMID:
10886535
9.

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage.

Serra MA, Rodríguez F, del Olmo JA, Escudero A, Rodrigo JM.

J Viral Hepat. 2003 May;10(3):183-8.

PMID:
12753336
10.

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T.

Gastroenterology. 1999 Feb;116(2):378-86.

PMID:
9922319
11.

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence.

Verbaan H, Widell A, Bondeson L, Andersson K, Eriksson S.

J Viral Hepat. 1998 Jan;5(1):43-51.

PMID:
9493516
12.

Contribution of obesity to hepatitis C-related fibrosis progression.

Ortiz V, Berenguer M, Rayón JM, Carrasco D, Berenguer J.

Am J Gastroenterol. 2002 Sep;97(9):2408-14.

PMID:
12358265
13.
14.

The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

Myers RP, Patel K, Pianko S, Poynard T, McHutchison JG.

J Viral Hepat. 2003 Jan;10(1):16-22.

PMID:
12558907
15.

Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection.

Murakami C, Hino K, Korenaga M, Okazaki M, Okuda M, Nukui K, Okita K.

J Clin Gastroenterol. 1999 Mar;28(2):148-52.

PMID:
10078824
16.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
17.

[Hepatitis C: a clinical-histopathological study].

Pálsson PS, Jónasson JG, Olafsson S.

Laeknabladid. 2008 Jan;94(1):13-7. Icelandic.

PMID:
18204107
18.

Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

Myers RP, Hilsden RJ, Lee SS.

J Viral Hepat. 2001 Jul;8(4):249-55.

PMID:
11454175
19.

Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C.

Svirtlih N, Jevtovic D, Simonovic J, Delic D, Dokic L, Gvozdenovic E, Boricic I, Nesic Z, Neskovic G, Urban V.

Hepatogastroenterology. 2007 Dec;54(80):2324-7.

PMID:
18265657
20.

Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.

Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F, Ferraro D, Cuccia L, Ruffo GB, Bronte F, Di Stefano R, Almasio PL, Craxì A.

Haematologica. 2008 Aug;93(8):1243-6. doi: 10.3324/haematol.12554. Epub 2008 Jun 12.

Supplemental Content

Support Center